September 30, 2020

The Niche

Knoepfler lab stem cell blog

National Right-To-Try

2 min read

The U.S. Senate just passed a bill that if it becomes law would codify Right-To-Try as a federal law, meaning terminally patients across the U.S. could ask their physicians and drug manufacturers to be given still investigational therapies such as still unproven stem cell therapies in development. The bill’s official name is “The Trickett Wendler Frank Mongiello Jordan McLinn,and Matthew Bellina Right to Try Act of 2017.” Its goal is summarized this way, “To authorize the use of unapproved medical products by patients diagnosed …Read More

2 min read

My recent post on the push for National Right-To-Try (RTT) including a detailed comment from ISSCR stirred some animated feedback. In the spirit of encouraging diverse discussion, here I am posting a striking comment I received from a stem cell industry insider regarding that post on RTT as it relates to stem cells and s/he was especially focused on the controversial new Texas stem cell law: “I understand we disagree about these things, but still a little disappointed in how prominent the “snake oil” salesman scare …Read More